12/9
10:49 am
naut
With 32% ownership, Nautilus Biotechnology, Inc. (NASDAQ:NAUT) insiders have a lot riding on the company's future [Yahoo! Finance]
Low
Report
With 32% ownership, Nautilus Biotechnology, Inc. (NASDAQ:NAUT) insiders have a lot riding on the company's future [Yahoo! Finance]
12/5
08:01 am
naut
Nautilus Biotechnology, Inc. (NASDAQ: NAUT) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "sell" rating. They now have a $1.75 price target on the stock.
Medium
Report
Nautilus Biotechnology, Inc. (NASDAQ: NAUT) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "sell" rating. They now have a $1.75 price target on the stock.
10/31
08:00 am
naut
Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research’s Distinguished Investigator Award
Low
Report
Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research’s Distinguished Investigator Award
10/30
08:00 am
naut
Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference
Medium
Report
Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference
10/29
08:00 am
naut
Nautilus Biotechnology Reports Third Quarter 2024 Financial Results
Medium
Report
Nautilus Biotechnology Reports Third Quarter 2024 Financial Results
10/8
08:00 am
naut
Nautilus Biotechnology to Announce Third Quarter 2024 Financial Results on October 29, 2024
Low
Report
Nautilus Biotechnology to Announce Third Quarter 2024 Financial Results on October 29, 2024